Sign inGet started

Brown Jason Parker

Insider CIK 1993170 · KRTX Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KRTX Karuna Therapeutics, Inc. D To issuer deriv2024-03-182024-03-187,696$160.91 $1.24M0SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer deriv2024-03-182024-03-187,100$138.21 $981.3K0SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer deriv2024-03-182024-03-1810,312$218.03 $2.25M0SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer deriv2024-03-182024-03-186,562$198.36 $1.30M0SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer deriv2024-03-182024-03-183,281$230.28 $755.5K0SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer deriv2024-03-182024-03-1810,306$330.00 $3.40M0SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer2024-03-182024-03-1814,009$330.00 $4.62M7,158SEC↗
KRTX Karuna Therapeutics, Inc. D To issuer2024-03-182024-03-187,158$330.00 $2.36M0SEC↗
KRTX Karuna Therapeutics, Inc. A Award deriv2024-02-132024-02-1510,306— $010,306SEC↗
KRTX Karuna Therapeutics, Inc. F Tax w/h2024-02-132024-02-15278$318.00 $88.4K21,167SEC↗
KRTX Karuna Therapeutics, Inc. A Award deriv2023-09-292023-10-037,696— $07,696SEC↗
KRTX Karuna Therapeutics, Inc. A Award2023-09-292023-10-034,496— $021,445SEC↗